BiodaticaThe bio-data intelligence layer for companies that aren’t on any ticker yet. Built entirely from public federal filings.
Biodatica publishes impersonal, generally-available research and analytics, identical for every subscriber. It is informational only, not investment advice, not a recommendation to buy or sell any security, and not tailored to anyone’s circumstances. Momentum and runway are estimates derived from public filings and may be wrong. Source data is drawn from U.S. government works (NIH RePORTER, ClinicalTrials.gov, SEC EDGAR, USPTO, openFDA, SBIR.gov); ClinicalTrials.gov data courtesy of the U.S. National Library of Medicine. Company and trial records belong to their filers.
© 2026 Biodatica · signal@biodatica.com